NCT07374003 2026-01-28Ipromlimab and Tuvonralimab Combined With Albumin-Bound Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell CarcinomaSun Yat-sen UniversityPhase 2 Active not recruiting62 enrolled